News

Jun 22, 2020 | News | Jerusalem & Area

In COVID-19 trials the elderly are often left out


A review carried out by Dr. Sharon K. Inouye, a geriatrician at Harvard Medical School and Hebrew SeniorLife found that elderly people have been excluded or underrepresented from a large quantity of COVID-19 related studies, a demographic disproportionately affected by the outbreak, reports the New York Times.  
While The US Centers for Disease Control reports that 80% of deaths in the United States caused by COVID-19 have occurred in people over the age of 65 or older, Dr. Inouye's research team found that in some COVID-19 trials, whether it be vaccine or otherwise related, specific age limits were set. They additionally found that in other trials, although age limits were not set, boundaries that could potentially exclude the elderly were.

Full Story (The Jerusalem Post)


Share: